Tyra Biosciences, Inc. - 8-K Filing
Tyra Biosciences held its 2026 Annual Meeting of Stockholders on May 28, 2026. Three Class II directors—Habib J. Dable, Susan Moran, M.D., and Robert More—were elected with votes ranging from 41 million to 44.5 million in favor. The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026 was ratified by a vote of 53,092,820 shares in favor. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $TYRA